The ProSense™ system is considered an optimal solution for treating fibroadenomas. Clinical studies conducted worldwide with results published in peer-reviewed medical journals demonstrate that cryoablation treatment enables shorter, simpler, and cost-effective procedures, with lower risk of infections and complications.
More information can be found in the recent American Society of Breast Surgeons (ASBS) guidelines announcement and the landmark US ICE3 clinical trial.